Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine
Michael D. Lesem(Claghorn Lesem Research Clinic), James V. Cassella(Trevi Therapeutics (United States)), Daniel A. Spyker(Alexza Pharmaceuticals (United States)), Tram Tran-Johnson, Robert Fishman, Michael H. Allen(East Tennessee State University), David Feifel(University of California San Diego), John H. Kehne, Robert Riesenberg
Cited by 153
Related Papers
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
|The Lancet|2018|780
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
|The Lancet|2017|474
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
|European Respiratory Journal|2015|462
The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
|Western Journal of Emergency Medicine|2012|386